Loading market dashboard
Upstream Bio, Inc.
UPBHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Upstream Bio, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $73.98M | $50.24M - $93.91M | -$73.98M | -$2.876 | 3 |
| Dec 2029 | $10.09M | $6.85M - $12.81M | -$10.09M | -$3.362 | 5 |
| Dec 2028 | $5.63M | $3.82M - $7.15M | -$5.63M | -$3.377 | 6 |
| Dec 2027 | $2.31M | $1.22M - $3.40M | -$2.31M | -$3.044 | 5 |
| Dec 2026 | $2.18M | $1.73M - $2.44M | -$2.18M | -$2.871 | 6 |
| Dec 2025 | $2.66M | $2.23M - $2.99M | -$2.66M | -$2.595 | 6 |
| Dec 2024 | $2.15M | $1.88M - $2.72M | -$2.15M | -$8.027 | 3 |